Trial · NCT01080677
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
Percentage of Participants Reporting Pain Relief at 2 Hrs Post First Administration of Caffeine/Propranolol (Defined as a Decrease in Headache Pain Intensity From Severe or Moderate Headache Pain at Baseline to Mild or no Pain at 2 Hrs) | Placebo | 10 | percentage of participants | ||
Percentage of Participants Reporting Pain Relief at 2 Hrs Post First Administration of Caffeine/Propranolol (Defined as a Decrease in Headache Pain Intensity From Severe or Moderate Headache Pain at Baseline to Mild or no Pain at 2 Hrs) | Low Dose | 45 | percentage of participants | ||
Percentage of Participants Reporting Pain Relief at 2 Hrs Post First Administration of Caffeine/Propranolol (Defined as a Decrease in Headache Pain Intensity From Severe or Moderate Headache Pain at Baseline to Mild or no Pain at 2 Hrs) | High Dose | 60 | percentage of participants | ||
| Percentage of Participants Pain Free at 2 Hrs Post First Administration of Caffeine/Propranolol | Placebo | 0 | percentage of participants | ||
| Percentage of Participants Pain Free at 2 Hrs Post First Administration of Caffeine/Propranolol | Low Dose | 20 | percentage of participants | ||
| Percentage of Participants Pain Free at 2 Hrs Post First Administration of Caffeine/Propranolol | High Dose | 35 | percentage of participants | ||
| Percentage of Participants Experiencing at Least One Adverse Event of Interest | Placebo | 10 | percentage of participants | ||
| Percentage of Participants Experiencing at Least One Adverse Event of Interest | Low Dose | 25 | percentage of participants | ||
| Percentage of Participants Experiencing at Least One Adverse Event of Interest | High Dose | 50 | percentage of participants | ||
| Percentage of Participants With Treatment Satisfaction | Placebo | 5 | percentage of participants | ||
| Percentage of Participants With Treatment Satisfaction | Low Dose | 40 | percentage of participants | ||
| Percentage of Participants With Treatment Satisfaction | High Dose | 80 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01080677/results